Influence of hypergammaglobulinemia on antiphospholipid antibodies titres;Étude de l'influence d'une hypergammaglobulinémie sur le titre des anticorps antiphospholipides

Revue de Medecine Interne

Volumn 25, Issue 2, 2004, Pages 111-114

  Lambert, M ^a   Fauchais, A L ^a   Dubucquoi, S ^a   Launay, D ^a   Caron, C ^a   Prin, L ^a   Hachulla, E ^a   Hatron, P Y ^a   Devulder, B ^a  

^a UNIV LILLE   (France)

Author keywords

Anticardiolipin; Antiphospholipid; False positive; Hypergammaglobulinemia

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; BIOLOGICAL MARKER;

ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; BIOASSAY; CONTROLLED STUDY; HUMAN; HYPERGAMMAGLOBULINEMIA; MAJOR CLINICAL STUDY; MOLECULAR EVOLUTION; NEOPLASM; THROMBOSIS; ADULT; BLOOD; FEMALE; LABORATORY DIAGNOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; BIOLOGICAL MARKERS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; HYPERGAMMAGLOBULINEMIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THROMBOSIS;

EID: 1442279371     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.revmed.2003.08.007     Document Type: Article

References (16)

1. Lockshin M.D., Sammaritano L.R., Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum. 43:2000;440-443.
2. Vila P., Hernandez M.C., Lopez-Fernandez M.F., Battle J. Prevalence, follow-up and clinical significance of the anticardiolipin in normal subjects. Thromb Haemost. 72:1994;209-213.
3. Petri M. Epidemiology of the Antiphospholipid Antibody Syndrome. J Autoimmun. 15:2000;145-151.
4. Galli M., Finazzi G., Norbis F., Marziali S., Marchioli R., Barbui T. The risk of thrombosis in patients with lupus anticoagulant is predicted by their specific coagulation profile. Thromb Haemost. 81:1999;695-700.
5. Qamar T., Levy R.A., Sammaritano L., Gharavi A.E., Lockshin M.D. Characteristics of high titer IgG antiphospholipid antibody in systemic lupus patients with and without fœtal death. Arthritis Rheum. 33:1990;501-504.
6. De Bandt M., Benali K., Guillevin L., Hachulla E., Job C., Fautrel B., et al. Longitudinal determination of antiphospholipid antibodies in lupus patients without previous manifestations of antiphospholipid syndrome. A prospective study. J Rheumatol. 26:1999;91-96.
7. Rosove M.H., Brewer P.M. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med. 117:1992;303-308.
8. Palareti G., Leali N., Cocheri S., Poggi M., Manotti C., D'Angelo A., et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet. 348:1996;423-428.
9. Lenzi R., Rand J.H., Spiera H. Anticardiolipin antibodies in pregnant patients with systemic lupus erythematosus (letter). N Engl J Med. 314:1986;1392-1393.
10. Hughes T.P., Jones P., Rozenberg M.C. Hypergammaglobulinemia and the anticardiolipin test. Arthritis Rheum. 32:1989;813.
11. Erkan D., Yacizi Y., Peterson M.G., Sammaritano L., Locksin M.D. A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology. 41:2002;924-929.
12. Brandt J.T., Triplett D.A., Alving B., Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant /Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost. 74:1995;1185-1190.
13. Estes D., Christian C.L. The natural history of systemic lupus erythematosus by prospective analysis. Medicine. 50:1971;85.
14. Horbach D.A., Van Oort E., Donders R.C., Derksen R.H., de Groot P.G. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Thromb Haemost. 76:1996;916-924.
15. Stern J.J., Ng R.H., Triplett D.A., McIntyre J.A. Incidence of antiphospholipid antibodies in patients with monoclonal gammapathy of undetermined significance. Am J Clin Pathol. 101:1994;471-474.
16. Vitali C., Sciuto M., Neri R., Greco F., Mavridis A.K., Tsioufas A.G., et al. Anti-hepatitis C virus antibodies in primary Sjogren's syndrome: false positive results are related to hypergammaglobulinemia. Clin Exp Rheumatol. 10:1992;103-104.